Shardul Amarchand Mangaldas & Co. advises Barentz in its acquisition of Anshul Life Sciences

Shardul Amarchand Mangaldas & Co. advised Barentz in its acquisition of Anshul Life Sciences.   Barentz is a leading global specialty ingredients solutions provider. With this acquisition, Barentz establishes a leading life science distribution platform in India and reinforces its commitment to providing innovative solutions and technical expertise pan-India.   The SAM & Co. team… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advises Brainbees Solutions Limited on its Initial Public Offering

Shardul Amarchand Mangaldas & Co. advised Brainbees Solutions Limited (“Issuer”) on its Initial Public Offering through a fresh issue and an offer for sale by SVF Frog (Cayman) Ltd, Mahindra & Mahindra Limited, PI Opportunities Fund- 1, TPG Growth V SF Markets Pte. Ltd., NewQuest Asia Investments III Limited, Ratan Tata and others (collectively, “Selling… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advises Juniper Networks, Inc on Securing an Unconditional Approval from the CCI for its $14 Billion Acquisition by Hewlett Packard Enterprise Company

Shardul Amarchand Mangaldas & Co. advised Juniper Networks, Inc. (“Juniper”) on securing an unconditional approval from the Competition Commission of India (CCI) for its USD 14 billion acquisition by Hewlett Packard Enterprise Company (“HPE”).   It is one of the largest deals in the global networking solutions sector.   The Competition Law team comprised of… Read More +

countinue reading